Public Release: 

Diagnostic tests are more accurate than estimates suggest

BioMed Central

Tests to diagnose endometrial hyperplasia, a condition where the uterus lining becomes overgrown, are more accurate than experiments have suggested. A study published this week in BMC Medicine shows that delays in verifying test results have led to underestimates of test accuracy.

Researchers from Birmingham Women's Hospital systematically reviewed all the published research on the accuracy of diagnostic tests for endometrial hyperplasia. They found that if researchers waited more than 24 hours to check test results, the accuracy of the original test was underestimated.

The researchers believe that, "to obtain accurate estimates of test accuracy in studies of hyperplasia, an immediate comparison of the test under scrutiny with a reference standard that verifies the diagnosis will be essential."

Endometrial hyperplasia is a benign condition that can lead to irregular or excessive vaginal bleeding. In most cases it is treatable with hormone therapy.

The condition is diagnosed by measuring the thickness of the uterus wall using ultrasound, or via a miniature biopsy of endometrial tissue. To test how accurate the diagnoses are a second sample of the uterus lining is taken, slides are made and assessed, and these results are compared to the original test results.

The researchers looked at 27 primary studies. In 16 of these, test results were checked within 24 hours. In three of the other 11, lab staff checked the test results within a week; in one, they waited up to six months to verify results. The researchers measured the effect of these delays on the apparent accuracy of the initial tests.

"The underestimation of test accuracy among studies with delayed verification was 74% on average compared to studies with immediate verification."

The group, led by Justin Clark, also assessed the quality of the published studies and found that in general the studies were poorly designed. For example, in many studies when lab staff were analysing slides to confirm test results, they were already aware of the outcome of the initial tests. This knowledge could well have biased their conclusions.

The researchers believe that, "poor study designs may reflect the situation prevalent in routine clinical practice where test results may not be immediately confirmed due to resource and other implications. Thus diagnostic evaluations carried out in routine practice may mask the accuracy of tests."

###

This press release is based on the following article: Bias associated with delayed verification in test accuracy studies: Accuracy of tests for endometrial hyperplasia may be much higher than we think. T Justin Clark, Gerben ter Riet, Aravinthan Coomarasamy and Khalid S Khan.
BMC Medicine 2004, 2:18
To be published 11 May 2004

Upon publication this article will be available free of charge as per BMC Medicine's Open Access policy at: http://www.biomedcentral.com/1741-7015/2/18

Please quote the journal in any stories you write, and link to the article if you are writing for the web.

For further information about this research, please contact Mr T. Justin Clark by phone on +44 (0)121 472 1377 ext 2702 or by email at: T.J.Clark@bham.ac.uk

Alternatively, or for further information about the journal or Open Access publishing, please contact Gemma Bradley by email at press@biomedcentral.com or by phone on +44-207-323-0323.

BMC Medicine (http://www.biomedcentral.com/bmcmed/) publishes original research articles, technical advances and study protocols in any area of medical science or clinical practice. To be appropriate for BMC Medicine, articles need to be of special importance and broad interest.

BMC Medicine is published by BioMed Central (http://www.biomedcentral.com), an independent online publishing house committed to providing Open Access to peer-reviewed biological and medical research. This commitment is based on the view that immediate free access to research and the ability to freely archive and reuse published information is essential to the rapid and efficient communication of science. BioMed Central currently publishes over 100 journals across biology and medicine. In addition to open-access original research, BioMed Central also publishes reviews, commentaries and other non-original-research content. Depending on the policies of the individual journal, this content may be open access or provided only to subscribers.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.